Search: Aurora

Aurora Cannabis (NASDAQ: ACB) is one of the most beaten-down cannabis stocks in the entire industry. Investors will recall that back in 2018, Aurora announced it was acquiring medical marijuana company MedReleaf for more than $2.5 billion in what at the time was the sector’s largest deal. Today, Aurora is worth about one-fifth of that value, with a market cap…

Aurora Cannabis (NASDAQ: ACB) announced in early June an additional round of cost-saving measures as part of its business transformation plan that has already brought on major adjustments to the company in the past two years. Aurora’s shares dropped throughout June after it bought back millions of dollars in convertible debt, announced it would close a major facility, and laid off…

There have been a slew of high profile layoff announcements in recent weeks as CEO’s prepare for what they expect to be a tough economic road ahead. While the electric vehicle maker will increase its hourly worker headcount — those Model 3s aren’t going to build themselves after all — the layoffs will affect about 3.5% of the company’s workforce.…

Aurora Cannabis rallied 6% in premarket trades on Friday after Cantor Fitzgerald analyst Pablo Zuanic upgraded the Canadian cannabis company to overweight from neutral and raised his 12-month price target on the stock to C$4.05 ($3.12) from C$3.90. Zuanic said Aurora Cannabis could benefit from growth in the legal cannabis market in Europe, as one of only two North American…

Aurora Cannabis rallied 6% in premarket trades on Friday after Cantor Fitzgerald analyst Pablo Zuanic upgraded the Canadian cannabis company to overweight from neutral and raised his 12-month price target on the stock to C$4.05 ($3.12) from C$3.90. Zuanic said Aurora Cannabis could benefit from growth in the legal cannabis market in Europe, as one of only two North American…

Shares of Aurora Cannabis (NASDAQ: ACB) crumbled by more than 11.7% on Monday as of noon ET amid a widespread decline in markets stemming from inflation concerns and the associated actions to control it as implemented by the Federal Reserve. Growth stocks are being hit particularly hard by the downturn, and to add insult to injury, cannabis stocks haven’t been…

Shares of Aurora Cannabis (NASDAQ: ACB) wafted nicely higher on the second day of the trading week. Interestingly, the latest analysis from Stifel is based largely on one habit of marijuana companies considered by many investors to be negative: a secondary share issue. Analyst W. Andrew Carter cited Aurora’s latest financing effort, in which it raised gross proceeds of $173…

Even if it’s not a huge purchase, we think it was good to see that Chitwant Kohli, the Independent Director of Aurora… READ MORE: https://finance.yahoo.com/news/trade-alert-independent-director-aurora-122145240.html?.tsrc=rss

Aurora Cannabis Inc. said Friday it has repurchased $20 million of convertible bonds in a move aimed at reducing its annual interest costs. The Edmonton, Alberta-based cannabis company said it paid $19.2 millin in cash for the notes, equal to a 5.25% discount to par value. The company expects its annual cash interest savings from the deal from the third…

Aurora Cannabis Inc. (“Aurora” or the “Company”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that it has repurchased an aggregate of approximately $25.3 million (US$20 million) principal amount of its convertible senior notes (“Notes”) at a total cost, including accrued interest, of $24.3 million (US$19.2 million) in cash. READ MORE: https://finance.yahoo.com/news/aurora-cannabis-repurchases-us-20-110000980.html?.tsrc=rss

In the habitually money-losing marijuana industry, new stock issues are a way of life for companies constantly hungry for fresh capital. Case in point: On Tuesday, Aurora Cannabis (NASDAQ: ACB) declined 5%-plus after it announced the closing of its latest issue. Aurora said that morning that it has raised gross proceeds of roughly $172.5 million from the issue, which technically isn’t…